HNRNPA1 and colorectal carcinoma: Therefore, we explored the expression of hnRNPA1, hnRNPM, and hnRNPK in drug-resistant CRC cells by analyzing GSE118490 and GSE11440, which showed that the expression of hnRNPA1, hnRNPM, and hnRNPK in drug-resistant CRC cells was relatively low (Figures 6G–L), which could reasonably explain the results of the survival curve.